FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893665080> ?p ?o ?g. }

• W2893665080 endingPage "5469" @default.
• W2893665080 startingPage "5462" @default.
• W2893665080 abstract "(5aR)-5a-C-pentyl-4-epi-isofagomine 1 is a powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B. We report herein an improved synthesis of this compound and analogs (5a-C-methyl, pentyl, nonyl and phenylethyl derivatives), and a crystal structure of a synthetic intermediate that confirms its configuration resulting from the addition of a Grignard reagent. These compounds were evaluated as glycosidase inhibitors and their potential as chaperones for mutant lysosomal galactosidases determined. Based on these results and on docking studies, the 5-C-pentyl derivative 1 was selected as the optimal structure for further investigations: this compound induces the maturation of mutated β-galactosidase in fibroblasts of a GM1-gangliosidosis patient and promote the decrease of keratan sulfate and oligosaccharide load in patient cells. Compound 1 is clearly capable of restoring β-galactosidase activity and of promoting maturation of the protein, which should result in significant clinical benefit. These properties strongly support the development of compound 1 for the treatment of GM1-gangliosidosis and Morquio disease type B patients harboring β-galactosidase mutations sensitive to pharmacological chaperoning." @default.
• W2893665080 created "2018-10-05" @default.
• W2893665080 creator A5004054989 @default.
• W2893665080 creator A5013717018 @default.
• W2893665080 creator A5018086281 @default.
• W2893665080 creator A5031210075 @default.
• W2893665080 creator A5031905326 @default.
• W2893665080 creator A5044484773 @default.
• W2893665080 creator A5049236772 @default.
• W2893665080 creator A5057453865 @default.
• W2893665080 creator A5065885421 @default.
• W2893665080 creator A5075079600 @default.
• W2893665080 creator A5087029559 @default.
• W2893665080 date "2018-11-01" @default.
• W2893665080 modified "2023-09-30" @default.
• W2893665080 title "4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations" @default.
• W2893665080 cites W1463302807 @default.
• W2893665080 cites W1963514249 @default.
• W2893665080 cites W1970041427 @default.
• W2893665080 cites W1974397398 @default.
• W2893665080 cites W1986326120 @default.
• W2893665080 cites W1987866052 @default.
• W2893665080 cites W2004580493 @default.
• W2893665080 cites W2015352658 @default.
• W2893665080 cites W2024575792 @default.
• W2893665080 cites W2047371368 @default.
• W2893665080 cites W2058754026 @default.
• W2893665080 cites W2059205366 @default.
• W2893665080 cites W2087861209 @default.
• W2893665080 cites W2105668062 @default.
• W2893665080 cites W2110775478 @default.
• W2893665080 cites W2116086639 @default.
• W2893665080 cites W2123310214 @default.
• W2893665080 cites W2130479394 @default.
• W2893665080 cites W2147001430 @default.
• W2893665080 cites W2194905180 @default.
• W2893665080 cites W2278298054 @default.
• W2893665080 cites W2325222131 @default.
• W2893665080 cites W2524140589 @default.
• W2893665080 cites W2592495635 @default.
• W2893665080 cites W2949490499 @default.
• W2893665080 cites W2950966335 @default.
• W2893665080 cites W2951636191 @default.
• W2893665080 doi "https://doi.org/10.1016/j.bmc.2018.09.023" @default.
• W2893665080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30270003" @default.
• W2893665080 hasPublicationYear "2018" @default.
• W2893665080 type Work @default.
• W2893665080 sameAs 2893665080 @default.
• W2893665080 citedByCount "12" @default.
• W2893665080 countsByYear W28936650802019 @default.
• W2893665080 countsByYear W28936650802020 @default.
• W2893665080 countsByYear W28936650802021 @default.
• W2893665080 countsByYear W28936650802022 @default.
• W2893665080 countsByYear W28936650802023 @default.
• W2893665080 crossrefType "journal-article" @default.
• W2893665080 hasAuthorship W2893665080A5004054989 @default.
• W2893665080 hasAuthorship W2893665080A5013717018 @default.
• W2893665080 hasAuthorship W2893665080A5018086281 @default.
• W2893665080 hasAuthorship W2893665080A5031210075 @default.
• W2893665080 hasAuthorship W2893665080A5031905326 @default.
• W2893665080 hasAuthorship W2893665080A5044484773 @default.
• W2893665080 hasAuthorship W2893665080A5049236772 @default.
• W2893665080 hasAuthorship W2893665080A5057453865 @default.
• W2893665080 hasAuthorship W2893665080A5065885421 @default.
• W2893665080 hasAuthorship W2893665080A5075079600 @default.
• W2893665080 hasAuthorship W2893665080A5087029559 @default.
• W2893665080 hasConcept C104317684 @default.
• W2893665080 hasConcept C143065580 @default.
• W2893665080 hasConcept C153074725 @default.
• W2893665080 hasConcept C159110408 @default.
• W2893665080 hasConcept C181199279 @default.
• W2893665080 hasConcept C185592680 @default.
• W2893665080 hasConcept C196032511 @default.
• W2893665080 hasConcept C2777249184 @default.
• W2893665080 hasConcept C2777878887 @default.
• W2893665080 hasConcept C2778230131 @default.
• W2893665080 hasConcept C2779553658 @default.
• W2893665080 hasConcept C41685203 @default.
• W2893665080 hasConcept C43053761 @default.
• W2893665080 hasConcept C547475151 @default.
• W2893665080 hasConcept C55493867 @default.
• W2893665080 hasConcept C71240020 @default.
• W2893665080 hasConcept C71924100 @default.
• W2893665080 hasConceptScore W2893665080C104317684 @default.
• W2893665080 hasConceptScore W2893665080C143065580 @default.
• W2893665080 hasConceptScore W2893665080C153074725 @default.
• W2893665080 hasConceptScore W2893665080C159110408 @default.
• W2893665080 hasConceptScore W2893665080C181199279 @default.
• W2893665080 hasConceptScore W2893665080C185592680 @default.
• W2893665080 hasConceptScore W2893665080C196032511 @default.
• W2893665080 hasConceptScore W2893665080C2777249184 @default.
• W2893665080 hasConceptScore W2893665080C2777878887 @default.
• W2893665080 hasConceptScore W2893665080C2778230131 @default.
• W2893665080 hasConceptScore W2893665080C2779553658 @default.
• W2893665080 hasConceptScore W2893665080C41685203 @default.
• W2893665080 hasConceptScore W2893665080C43053761 @default.
• W2893665080 hasConceptScore W2893665080C547475151 @default.
• W2893665080 hasConceptScore W2893665080C55493867 @default.

• next